Form 4 for MXL MAXLINEAR, INC
Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-20 · accession 0001288469-25-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-24 | 2025-02-20 | MXL | Kwong Connie H. | Corp. Ctrl, PAO | A - Grant | $0.00 | +783 | 49.9K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | A | A | 783 | $0.00 | 49,930 | D | — | — | (F1) Represents shares of Common Stock issued to the Reporting Person for the 2024 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's Amended and Restated 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 20, 2025. The Reporting Person has deferred settlement of the shares until March 3, 2025. |